PRESS RELEASE published on 10/26/2023 at 14:30, 2 years 9 months ago Jaguar Health to Present November 1st at Emerging Growth Conference
PRESS RELEASE published on 10/23/2023 at 14:30, 2 years 9 months ago Magdalena Biosciences Initiates Preclinical Study to Evaluate Plant Extracts to Treat Depression, Anxiety, ADHD and Other Mental Health Indications
PRESS RELEASE published on 10/19/2023 at 14:30, 2 years 9 months ago Independent Study Conducted at Boston Children's Hospital, Harvard Medical School, Shows Potential Utility of Jaguar Health's Crofelemer for Treatment of MVID, a Rare Childhood Disease
PRESS RELEASE published on 10/18/2023 at 14:30, 2 years 9 months ago Napo Pharmaceuticals to Exhibit at the October 25-28 Annual Association of Nurses in AIDS Care (ANAC) Conference for Mytesi, the Company’s FDA-Approved Prescription Drug
PRESS RELEASE published on 10/12/2023 at 14:30, 2 years 10 months ago Jaguar Health to Present October 17 at the Lytham Partners Fall 2023 Investor Conference and October 18 at the BIO Investor Forum
PRESS RELEASE published on 10/10/2023 at 14:30, 2 years 10 months ago Jaguar Animal Health Exhibiting at October 12-14 VCS Annual Conference for Canalevia-CA1, the Company's FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
PRESS RELEASE published on 09/28/2023 at 14:30, 2 years 10 months ago Jaguar Health to Present October 3 at LD Micro's Main Event Investor Conference, and on October 5 at the Global Capital Network Investor Conference
PRESS RELEASE published on 09/27/2023 at 14:30, 2 years 10 months ago Jaguar Health Launches TikTok and Instagram Contest to Raise Awareness About Common Yet Barely Addressed Health Condition: Surprise Diarrhea
PRESS RELEASE published on 09/26/2023 at 14:30, 2 years 10 months ago Napo Pharmaceuticals Supports Groundbreaking Study on Quality of Life for Cancer Patients and Survivors
PRESS RELEASE published on 09/21/2023 at 13:30, 2 years 10 months ago Jaguar Health Announces Import of Coca Leaf From Peru by Joint Venture Magdalena Biosciences for Research in Treating ADHD
Published on 08/12/2026 at 23:30, 53 minutes ago CCL Industries Announces Record Results for 2026 Second Quarter
Published on 08/12/2026 at 23:30, 53 minutes ago Bolt Metals to Rebrand as 26 Metals Inc. and Adopt the Ticker "IRON," Highlighting Its Focus on Flagship Florália Iron Project in Brazil's Iron Quadrangle
Published on 08/12/2026 at 23:20, 1 hour 3 minutes ago RJK Explorations Ltd. Announces Upsize of Previously Announced Private Placement
Published on 08/12/2026 at 23:05, 1 hour 18 minutes ago Vox Royalty Reports Q2 2026 Results And Declares Quarterly Dividend
Published on 08/12/2026 at 22:01, 2 hours 22 minutes ago Fermi Names Lee McIntire as Chief Executive Officer
Published on 08/12/2026 at 21:05, 3 hours 18 minutes ago Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA
Published on 08/12/2026 at 19:57, 4 hours 26 minutes ago EQS-Adhoc: Hypoport SE: Hypoport SE resolves share buyback programme with a volume of up to EUR 10 million
Published on 08/12/2026 at 19:37, 4 hours 45 minutes ago EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for H1 2026 at €13.4 million and adjusted EBITDA at €-0.5 million; forecast for the continuing operations unchanged
Published on 08/11/2026 at 17:45, 1 day 6 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 6 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 6 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 6 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
